glp 1 with blue cross blue shield GLP-1 Drugs Could Raise Employer Health Premiums Anthem Blue Cross Blue Shield

Food and Drug Administration has recently identified drug-induced alopecia (hair loss) as an adverse event for patients taking GLP-1 medications

GIP receptor activation Glucose-dependent insulinotropic polypeptide, or GIP, was long considered a problem hormone

As covered above, the "10,978" and "10,257" review counts shown on the same landing page don't match each other

These can include: Digestive issues that could lead to dehydration and cause kidney damage Gastrointestinal issues like pancreatitis or gallbladder disease Low blood pressure Low blood sugar levels There is also a black box warning, the most serious kind from the FDA, on both medications for the risk of a certain rare type of thyroid cancer

Clinical trials show that this drug may help a lot with weight loss and glycemic control